Medication Brand Name(s) Form & Frequency Target Mechanism FDA Status Typical Weight Loss Notes Semaglutide Ozempic, Wegovy, Wegovy HD Weekly injection; oral daily tablet GLP-1 Approved 10–15% (HD dose higher)...
Medication Brand Name(s) Form & Frequency Target Mechanism FDA Status Typical Weight Loss Notes Semaglutide Ozempic, Wegovy, Wegovy HD Weekly injection; oral daily tablet GLP-1 Approved 10–15% (HD dose higher)...

About 10 percent of those who take Wegovy, Zepbound, etc. do not experience the results they seek, according to a New York Times article. “Over 15 months on Zepbound, Ms....

By Michael PragerChairman There are the causes of disordered eating. And there are the popular remedies for it. GLP-1s are the unprecedented, overwhelming favorites right now, hailed as life-changing by...

This article is adapted from a MATTERS Network article written by Lucy Connery, MPH & Brooke Langella, MPH. By Asha Velor GLP-1s — such as tirzepatide and semaglutide, more commonly...

The National Academy of Medicine summarizes a conversation among specialists from two universities, the Cato Institute, and the Obesity Action Coalition about the current state of GLP-1s. Here are some...
Lorem Ipsum is simply dumy text of the printing typesetting industry.